Scand J Urol Nephrol
-
Scand J Urol Nephrol · Jan 2005
Randomized Controlled Trial Comparative Study Clinical TrialLocal anesthesia in transrectal ultrasound-guided prostate biopsy: EMLA cream as a new alternative technique.
The aims of the present study were to evaluate the efficacy of eutectic mixture of local anesthetics (EMLA) cream in transrectal-guided prostate biopsy and to compare its effect with that of other injectable anesthetic procedures. ⋯ Intrarectal application of EMLA cream provides equal anesthesia to periprostatic nerve blockade with prilocaine and lidocaine.
-
Scand J Urol Nephrol · Jan 2005
Case ReportsGenitourinary manifestations of Klippel-Trenaunay syndrome: report of two cases managed with systemic alpha-interferon.
We present our experience of two cases with genitourinary manifestations of Klippel-Trenaunay syndrome. A MEDLINE search for the period 2001-2004 was done using the keywords "Klippel-Trenaunay syndrome", "vascular malformation" and "genitourinary". ⋯ Genitourinary problems are rare in Klippel-Trenaunay syndrome; however, their management may be a challenge for the urologist. In one of our patients who failed to respond to endoscopic laser coagulation and partial cystectomy we used systemic alpha-interferon, with a good short-term response.
-
Scand J Urol Nephrol · Jan 2005
Comparative StudyBulboprostatic anastomotic urethroplasty with preservation of potency: anatomical study, operative approach and clinical results.
OBJECTIVE. To identify the precise anatomy of the membranous and bulbous urethrae and their relation to the neurovascular bundles (cavernous nerves and vessels). Based on the findings, a modified surgical technique was developed to preserve potency by avoiding injury to the neurovascular bundles during surgery on the posterior urethra. ⋯ Our technique of neurovascular bundle preservation during bulboprostatic anastomotic urethroplasty may solve the problem of postoperative impotence.
-
Scand J Urol Nephrol · Jan 2004
ReviewTraditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Cardiovascular disease (CVD) remains the main cause of morbidity and mortality in patients with end-stage renal disease (ESRD). Although traditional risk factors, such as diabetes mellitus, hypertension, dyslipidemia and advanced age, are prevalent in ESRD patients they may not be sufficient by themselves to account for the high prevalence of CVD in patients with this condition. Thus, the search for other, non-traditional, risk factors that may be involved in the pathogenesis of uremic CVD has been an area of intense study. ⋯ Thus, it could be speculated that suppression of the vicious cycle of malnutrition, inflammation and atherosclerosis (MIA syndrome) would improve survival in dialysis patients. Recent evidence has demonstrated strong associations between inflammation and both increased oxidative stress and endothelial dysfunction in ESRD patients. As there is not yet any recognized, or even proposed, treatment for ESRD patients with chronic inflammation it would be of obvious interest to study the long-term effect of various anti-inflammatory treatment strategies on the nutritional and cardiovascular status as well as outcome of these patients.
-
Scand J Urol Nephrol · Jan 2004
Management of urinary incontinence after bulboprostatic anastomotic urethroplasty for posterior urethral obstruction secondary to pelvic fracture.
To present our experience of the management of urinary incontinence after bulboprostatic anastomotic urethroplasty for post-traumatic posterior urethral obstruction secondary to pelvic fracture. ⋯ The proximal sphincteric mechanism should be fully evaluated before performing bulboprostatic anastomosis. Placement of a bladder tube is a good option for managing urinary incontinence. Vesicourethral fistulae are an unrecognized cause of urinary incontinence following transpubic urethroplasty. Visual urethrotomy should only be used in short, passable strictures.